Wenli Diao
321 Zhongshan Rd
Nanjing, 210008, China
Nanjing, 210008, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Entinostat overcomes cisplatin resistance in bladder cancer by promoting H3K18la-mediated DHRS2 expression and nuclear translocation to suppress the AKR1C3-androgen axis.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: October 11, 2025
SNW1 promotes lymphatic metastasis in bladder cancer by modulating SRPK1 splicing.
Journal: iScience
Published: September 30, 2025
HDAC2 as a therapeutic target in bladder cancer: insights into the altered epigenetic regulation and lysine lactylation.
Journal: Journal of experimental & clinical cancer research : CR
Published: July 03, 2025
GSTA1 deficiency drives neuroendocrine differentiation via TNFRSF13B/c-FOS/CHGA axis in prostate cancer.
Journal: International journal of biological sciences
Published: June 28, 2025
SFXN1 promotes bladder cancer metastasis by restraining PINK1-dependent mitophagy.
Journal: Oncogene
Published: December 03, 2024
Tumor-intrinsic RGS1 potentiates checkpoint blockade response via ATF3-IFNGR1 axis.
Journal: Oncoimmunology
Published: January 24, 2024
GALNT12 suppresses the bone-specific prostate cancer metastasis by activating BMP pathway via the O-glycosylation of BMPR1A.
Journal: International journal of biological sciences
Published: November 25, 2023
Multi-cohort validation of Ascore: an anoikis-based prognostic signature for predicting disease progression and immunotherapy response in bladder cancer.
Journal: Molecular cancer
Published: October 05, 2023
MIOX inhibits autophagy to regulate the ROS -driven inhibition of STAT3/c-Myc-mediated epithelial-mesenchymal transition in clear cell renal cell carcinoma.
Journal: Redox biology
Published: October 02, 2023
Last Updated: 09/26/2026